Published in Vet Immunol Immunopathol on December 01, 1992
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J Virol (1994) 1.41
Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol (1995) 1.14
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J Virol (1994) 1.08
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol (1996) 1.03
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol (2002) 0.95
A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology (2008) 0.87
Feline immunodeficiency virus model for designing HIV/AIDS vaccines. Curr HIV Res (2010) 0.86
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose. Retrovirology (2014) 0.85
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection. Retrovirology (2011) 0.85
AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens. J Virol (2006) 0.83
Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology (1995) 0.82
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J Virol (2005) 0.80
Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. J Virol (1997) 0.78
Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects. Hum Vaccin Immunother (2015) 0.77
Evidence for tumour necrosis factor/cachectin production in cancer. Lancet (1987) 3.66
The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res (1999) 3.29
Functional human corneal equivalents constructed from cell lines. Science (1999) 2.74
Office gel sonovaginography for the prediction of posterior deep infiltrating endometriosis: a multicenter prospective observational study. Ultrasound Obstet Gynecol (2014) 2.67
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun (1985) 2.23
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
An unusual sequela to an inferior dental block injection. Br Dent J (1995) 2.02
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol (1991) 1.95
Analgesic activity of morphine-6-glucuronide. Lancet (1988) 1.94
Minireview: genomic organization of the human ERalpha gene promoter region. Mol Endocrinol (2001) 1.87
Dual energy computed tomography in tophaceous gout. Ann Rheum Dis (2008) 1.83
Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol (1987) 1.77
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol (1996) 1.71
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
Characterization of a 105,000 molecular weight gag-related phosphoprotein from cells transformed by the defective avian sarcoma virus PRCII. Virology (1981) 1.67
Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch (1995) 1.67
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Common mechanism of infection by lentiviruses. Nature (1997) 1.47
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol (2002) 1.42
Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis (1987) 1.41
Reliability and validity of three fitness tests for adults with mental handicaps. Can J Sport Sci (1992) 1.40
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol (2001) 1.39
The variability of blood pressure measurements in children. Am J Public Health (1983) 1.38
A two-year longitudinal study of stressful life events, social support, and social problem-solving skills: contributions to children's behavioral and academic adjustment. Child Dev (1991) 1.37
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol (1998) 1.36
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene (1995) 1.35
Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol (1994) 1.34
Replication of cat leukemia virus in cell cultures. Nature (1968) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol (2009) 1.32
Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem (2001) 1.31
Detection of a Lactobacillus substance that inhibits Escherichia coli. Can J Microbiol (1988) 1.28
The pathogenicity and defectiveness of PRCII: a new type of avian sarcoma virus. Virology (1981) 1.28
Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol (1999) 1.28
Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol (2007) 1.27
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol (2009) 1.27
Changes in excitability and accommodation of human motor axons following brief periods of ischaemia. J Physiol (1991) 1.27
TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol (2000) 1.26
Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis (1992) 1.25
Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst (1971) 1.25
Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology (1991) 1.25
Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene (2001) 1.25
Isolation of the nucleic acid of feline leukemia virus. Virology (1971) 1.25
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24
Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiol Lett (2000) 1.24
A study of naturally occurring feline coronavirus infections in kittens. Vet Rec (1992) 1.24
Evidence for three classes of avian sarcoma viruses: comparison of the transformation-specific proteins of PRCII, Y73, and Fujinami viruses. Proc Natl Acad Sci U S A (1981) 1.24
Isolation of bluetongue and related viruses from Culicoides spp. in the Sudan. J Hyg (Lond) (1984) 1.23
Esh avian sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein kinase activity. Virology (1981) 1.23
Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol (1988) 1.22
A third class of avian sarcoma viruses, defined by related transformation-specific proteins of Yamaguchi 73 and Esh sarcoma viruses. Proc Natl Acad Sci U S A (1981) 1.22
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol (1985) 1.22
Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. Virology (1980) 1.21
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology (1996) 1.21
Is there a need for a place-of-work cervical smear service? Health Bull (Edinb) (1988) 1.20
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J Virol (1998) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse. J Mol Endocrinol (2002) 1.19
Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain (1995) 1.18
Response to "randomized vertebroplasty trials: bad news or sham news?". AJNR Am J Neuroradiol (2009) 1.18
Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med (1994) 1.18
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol (1990) 1.17
Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells. Lab Invest (1992) 1.16
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene (1999) 1.16
A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J Virol (1993) 1.15
Myristoylation-dependent binding of HIV-1 Nef to CD4. J Mol Biol (1994) 1.15
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol (2011) 1.13
Selective effect of feline leukaemia virus on early erythroid precursors. Nature (1982) 1.12
Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. J Endourol (1998) 1.11
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
Retroviral transduction of T-cell antigen receptor beta-chain and myc genes. Nature (1987) 1.11
Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J Virol (1998) 1.11
In vitro attachment of Escherichia coli to human uroepithelial cells: variation in receptivity during the menstrual cycle and pregnancy. J Infect Dis (1983) 1.11